Neuro Regulatory CND Life Sciences is Granted FDA Breakthrough Device Designation for Its Skin Biopsy-Based Syn-One Test® byNoah SimmonsOctober 7, 2025
Biologics RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis byJosh SandbergJune 30, 2015
